Description
NSE updates Enhanced Surveillance Measure framework with two securities added to Stage I and 100% margin requirement effective February 04, 2026.
Summary
NSE has updated its Enhanced Surveillance Measure (ESM) framework, adding two securities to Stage I effective February 03, 2026. The affected securities will attract a minimum 100% margin requirement and will be shifted from Rolling Settlement segment (EQ/SM) to Trade-for-Trade segment (BE/ST) starting February 04, 2026. This surveillance action applies to both open positions as on February 03, 2026 and new positions created from February 04, 2026 onwards.
Key Points
- Two securities added to ESM Stage I: Paras Petrofils Limited (PARASPETRO) and Vilin Bio Med Limited (VILINBIO)
- No securities moving between Stage I and Stage II
- No securities being excluded from ESM framework
- Securities shifting to Stage II will be under Trade for Trade with 2% price band under Periodic Call Auction
- ESM framework operates in conjunction with all other prevailing surveillance measures
- This is a market surveillance action and not an adverse action against the companies
Regulatory Changes
The circular implements the following changes under the Enhanced Surveillance Measure framework:
- Stage I Additions: PARASPETRO and VILINBIO newly included in ESM Stage I
- Segment Transfer: Securities will move from Rolling Settlement (Series: EQ/SM) to Trade-for-Trade segment (Series: BE/ST)
- Margin Requirements: Minimum 100% margin applicable on all positions
- Stage II Requirements: Securities in Stage II operate under Trade for Trade with 2% price band under Periodic Call Auction mechanism
Compliance Requirements
For Market Participants:
- Ensure adequate margin coverage of 100% minimum for positions in affected securities
- Adjust trading strategies for Trade-for-Trade settlement requirement
- Monitor consolidated list of ESM securities (currently includes ANONDITA and DHARIWAL in Stage II)
- Comply with all prevailing surveillance measures applicable to these securities
For Brokers/Trading Members:
- Update risk management systems to reflect new margin requirements
- Communicate changes to clients holding positions in affected securities
- Direct queries to surveillance@nse.co.in
Important Dates
- February 02, 2026: Circular issued (Circular Ref. No: 81/2026, Download Ref: NSE/SURV/72575)
- February 03, 2026: Securities added to ESM Stage I; 100% margin applicable on open positions; Stage II securities move to Periodic Call Auction with 2% price band
- February 04, 2026: 100% margin applicable on new positions; segment shift from EQ/SM to BE/ST effective
Impact Assessment
Trading Impact:
- Significantly reduced liquidity for PARASPETRO and VILINBIO due to Trade-for-Trade requirement
- Higher capital requirements for traders due to 100% margin mandate
- Limited intraday trading opportunities in affected securities
- Potential price volatility during transition period
Market Impact:
- Enhanced scrutiny indicates potential concerns about price movements or trading patterns
- Investor confidence may be affected in the short term
- Long-only investors less impacted compared to active traders
Reference Information:
- Consolidated ESM list includes Stage II securities: Anondita Medicare Limited (ANONDITA) and Dhariwalcorp Limited (DHARIWAL)
- ISINs: PARASPETRO (INE162C01024), VILINBIO (INE0L4V01013)
- For detailed ESM framework information: https://www.nseindia.com/regulations/enhanced-surveillance-measure-esm
Impact Justification
Imposition of 100% margin and shift to Trade-for-Trade segment significantly restricts trading for affected securities